Get the Stockscreener App
93.85
2.02%
1.86
After Hours:
93.85
Overview
News
Price History
Option Chain
Financials
Why GEHC Down?
Discussions
Forecast
Dividend History
Ge Healthcare Technologies Inc stock is traded at $93.85, with a volume of 3.91M.
It is up +2.02% in the last 24 hours and up +10.65% over the past month.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
See More
Previous Close:
$91.99
Open:
$92.51
24h Volume:
3.91M
Relative Volume:
1.35
Market Cap:
$42.56B
Revenue:
$19.52B
Net Income/Loss:
$1.58B
P/E Ratio:
27.20
EPS:
3.45
Net Cash Flow:
$1.62B
1W Performance:
+3.27%
1M Performance:
+10.65%
6M Performance:
+3.23%
1Y Performance:
+37.93%
1-Day Range:
$92.39
$94.32
1-Week Range:
$89.38
$94.55
52-Week Range:
$62.35
$94.55
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Name
Ge Healthcare Technologies Inc
Sector
Industry
Phone
833-735-1139
Address
500 WEST MONROE STREET, CHICAGO
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Initiated | HSBC Securities | Buy |
| Feb-12-24 | Upgrade | UBS | Sell → Neutral |
| Nov-30-23 | Initiated | Jefferies | Hold |
| Nov-27-23 | Downgrade | UBS | Neutral → Sell |
| Sep-19-23 | Initiated | Citigroup | Buy |
| Aug-25-23 | Initiated | Argus | Buy |
| Aug-16-23 | Initiated | Wells Fargo | Overweight |
| Jul-31-23 | Initiated | BofA Securities | Neutral |
| Jun-27-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-16-23 | Initiated | Oppenheimer | Outperform |
| Apr-26-23 | Initiated | UBS | Neutral |
| Apr-19-23 | Initiated | Piper Sandler | Overweight |
| Apr-10-23 | Initiated | BTIG Research | Neutral |
| Mar-13-23 | Initiated | Evercore ISI | Outperform |
| Feb-17-23 | Initiated | Mizuho | Buy |
| Jan-19-23 | Initiated | Redburn | Buy |
View All
Ge Healthcare Technologies Inc Stock (GEHC) Latest News
FDA approves GE Healthcare’s Flyrcado for CAD diagnosis - BioWorld Online
Global Chronic Disease Management Market Size to Reach USD 17.28 Billion by 2033 | Witnessing a CAGR of 12.80% - GlobeNewswire Inc.
GE HealthCare stock target raised, keeps buy on FDA nod for new drug - Investing.com India
(GEHC) Trading Report - Stock Traders Daily
GE HealthCare Technologies (NASDAQ:GEHC) PT Raised to $102.00 at Stifel Nicolaus - MarketBeat
GE HealthCare’s Flyrcado PET radiotracer secures FDA approval - Medical Device Network
Lighthouse Investment Partners LLC Sells 33,277 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) - MarketBeat
In-vitro Fertilization Market to hit USD 32.9 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
MBB Public Markets I LLC Buys Shares of 30,635 GE HealthCare Technologies Inc. (NASDAQ:GEHC) - MarketBeat
Is GE Healthcare Technologies Inc. (GEHC) the Best Young Stock To Buy Now? - Insider Monkey
Is GE Healthcare Technologies Inc. (GEHC) the Best Young Stock To Buy Now? - Yahoo Finance
GE HealthCare Technologies (NASDAQ:GEHC) Reaches New 52-Week High at $94.55 - MarketBeat
GE Healthcare initiated with Neutral at J.P. Morgan - MSN
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by APG Asset Management N.V. - MarketBeat
US FDA approves GE HealthCare's diagnostic drug for heart disease - Reuters
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease - sharewise
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease - Business Wire
UBS downgrades GE Healthcare to 'sell' citing overvaluation and China risk - MSN
Axial Bone Densitometer Market to Reach $1.0 Billion, Globally, by 2033 at 3.9% CAGR: Allied Market Research - GlobeNewswire Inc.
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Acquires 33,938 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) - MarketBeat
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024 - BioSpace
UBS warns GE HealthCare stock faces China risk and lower growth outlook - Investing.com Australia
GE HealthCare showcases oncology innovations at ASTRO By Investing.com - Investing.com South Africa
GE HealthCare showcases oncology innovations at ASTRO - Investing.com India
UBS Group Lowers GE HealthCare Technologies (NASDAQ:GEHC) to Sell - MarketBeat
Why One GE Stock Is On Fire, Another Is Cooling Off - Barron's
UBS warns GE HealthCare stock faces China risk and lower growth outlook - Investing.com Canada
GE HealthCare showcases oncology innovations at ASTRO - Investing.com
GE HealthCare cut to sell by UBS over Chinese competition concerns (NASDAQ:GEHC) - Seeking Alpha
Analyst: Healthcare Stock Faces 2 Key Pressure Points - Schaeffers Research
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024 - StockTitan
UBS warns GE HealthCare stock faces China risk and lower growth outlook - Investing.com
UBS downgrades GE Healthcare to 'sell' citing overvaluation and China risk - Investing.com Australia
UBS downgrades GE Healthcare to 'sell' citing overvaluation and China risk - Investing.com Canada
UBS downgrades GE Healthcare to 'sell' citing overvaluation and China risk - Investing.com
GE Healthcare: UBS now Sell - Marketscreener.com
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Bank of Montreal Can - MarketBeat
UBS warns GE HealthCare stock faces China risk and lower growth outlook - Investing.com UK
GE Healthcare raised to Buy at BTIG on potential H2 beat - MSN
Patient Centric Healthcare App Market Report 2024Drivers, Forecast - WhaTech
Global Contrast Media Market is Expected to Develop at a High 7.4% CAGR through 2031 | SkyQuest Technology - Benzinga
GE HealthCare Technologies Inc. (GEHC): Hedge Funds Are Bullish On This Trending AI Stock Right Now - Insider Monkey
GE HealthCare Technologies Inc. (GEHC): Hedge Funds Are Bullish On This Trending AI Stock Right Now - Yahoo Finance
AE Wealth Management LLC Acquires 11,938 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) - MarketBeat
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Jim Cramer Says GE HealthCare Technologies Inc. (GEHC) Is ‘No Longer Counting On China For Growth’ - Insider Monkey
Jim Cramer Says GE HealthCare Technologies Inc. (GEHC) Is ‘No Longer Counting On China For Growth’ - Yahoo Finance
10 Trending AI Health Stocks - Insider Monkey
AI in Healthcare Set for Explosive Growth with Projections Hitting $613 Billion by 2034 - Baystreet.ca
HighVista Strategies LLC Takes $1.26 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) - MarketBeat
Pacer Advisors Inc. Acquires 15,312 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) - MarketBeat
Ge Healthcare Technologies Inc Stock (GEHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):